Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;33(1):15-20.
doi: 10.1055/s-0036-1572355.

The Biology of Hemodialysis Vascular Access Failure

Affiliations
Review

The Biology of Hemodialysis Vascular Access Failure

Akshaar Brahmbhatt et al. Semin Intervent Radiol. 2016 Mar.

Abstract

Arteriovenous fistulas (AVFs) are essential for patients and clinicians faced with end-stage renal disease (ESRD). While this method of vascular access for hemodialysis is preferred to others due to its reduced rate of infection and complications, they are plagued by intimal hyperplasia. The pathogenesis of intimal hyperplasia and subsequent thrombosis is brought on by uremia, hypoxia, and shear stress. These forces upregulate inflammatory and proliferative cytokines acting on leukocytes, fibroblasts, smooth muscle cells, and platelets. This activation begins initially with the progression of uremia, which induces platelet dysfunction and primes the body for an inflammatory response. The vasculature subsequently undergoes changes in oxygenation and shear stress during AVF creation. This propagates a strong inflammatory response in the vessel leading to cellular proliferation. This combined response is then further subjected to the stressors of cannulation and dialysis, eventually leading to stenosis and thrombosis. This review aims to help interventional radiologists understand the biological changes and pathogenesis of access failure.

Keywords: arteriovenous fistula failure; end stage renal disease; hemodialysis; interventional radiology; intimal hyperplasia.

PubMed Disclaimer

References

    1. Sands J J. Increasing AV fistulas: revisiting a time-tested solution. Semin Dial. 2000;13(6):351–353. - PubMed
    1. Rayner H C, Pisoni R L. The increasing use of hemodialysis catheters: evidence from the DOPPS on its significance and ways to reverse it. Semin Dial. 2010;23(1):6–10. - PubMed
    1. Lopez-Vargas P A, Craig J C, Gallagher M P. et al.Barriers to timely arteriovenous fistula creation: a study of providers and patients. Am J Kidney Dis. 2011;57(6):873–882. - PubMed
    1. Vassalotti J A, Jennings W C, Beathard G A. et al.Fistula first breakthrough initiative: targeting catheter last in fistula first. Semin Dial. 2012;25(3):303–310. - PubMed
    1. Schinstock C A, Albright R C, Williams A W. et al.Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011;6(8):1996–2002. - PMC - PubMed